BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 309816)

  • 1. The effect of quipazine, a serotonin receptor agonist, on serum corticosterone concentration in rats.
    Fuller RW; Snoddy HD; Clemens JA
    Endocr Res Commun; 1978; 5(2):161-71. PubMed ID: 309816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of metergoline and other serotonin receptor antagonists on serum corticosterone in rats.
    Fuller RW; Snoddy HD
    Endocrinology; 1979 Oct; 105(4):923-8. PubMed ID: 477605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin receptor subtypes involved in the elevation of serum corticosterone concentration in rats by direct- and indirect-acting serotonin agonists.
    Fuller RW; Snoddy HD
    Neuroendocrinology; 1990 Aug; 52(2):206-11. PubMed ID: 2148812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonergic stimulation of pituitary-adrenal activity in the mouse.
    Meyer JS; Buckholtz NS; Boggan WO
    Neuroendocrinology; 1978; 26(5):312-24. PubMed ID: 150549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The acute effects of 5HTP, fluoxetine and quipazine on insulin and glucagon release in the intact rat.
    Jacoby JH; Bryce GF
    Horm Metab Res; 1979 Feb; 11(2):90-4. PubMed ID: 312241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological evidence for a role of brain serotonin in the maintenance of plasma renin activity in unanesthetized rats.
    Van de Kar LD; Wilkinson CW; Ganong WF
    J Pharmacol Exp Ther; 1981 Oct; 219(1):85-90. PubMed ID: 6457138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anorexia and brain serotonin: development of tolerance to the effects of fenfluramine and quipazine in rats with serotonin-depleting lesions.
    Carlton J; Rowland N
    Pharmacol Biochem Behav; 1984 May; 20(5):739-45. PubMed ID: 6610879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of imipramine and serotonin-2 agonists and antagonists on serotonin-2 and beta-adrenergic receptors following noradrenergic or serotonergic denervation.
    Eison AS; Eison MS; Yocca FD; Gianutsos G
    Life Sci; 1989; 44(19):1419-27. PubMed ID: 2785627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin-like actions of quipazine and CPP on spinal motoneurones.
    Neuman RS; White SR
    Eur J Pharmacol; 1982 Jun; 81(1):49-56. PubMed ID: 7117370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agonist and antagonist properties of serotonergic compounds in pigeons trained to discriminate either quipazine or L-5-hydroxytryptophan.
    Yamamoto T; Walker EA; Woods JH
    J Pharmacol Exp Ther; 1991 Sep; 258(3):999-1007. PubMed ID: 1890629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The response of suprachiasmatic neurons of the rat hypothalamus to photic and serotonergic stimulation.
    Miller JD; Fuller CA
    Brain Res; 1990 May; 515(1-2):155-62. PubMed ID: 2357553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of 5-HT2A receptors in the elevation of rat serum corticosterone concentrations by quipazine and MK-212.
    Hemrick-Luecke SK; Fuller RW
    Eur J Pharmacol; 1996 Sep; 311(2-3):207-11. PubMed ID: 8891601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonergic stimulation of prolactin release in the young turkey (Meleagris gallopavo).
    Fehrer SC; Silsby JL; El Halawani ME
    Gen Comp Endocrinol; 1983 Dec; 52(3):400-8. PubMed ID: 6230284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of midbrain raphe lesion or 5,7-dihydroxytryptamine treatment on the prolactin-releasing action of quipazine and D-fenfluramine in rats.
    Quattrone A; Schettini G; di Renzo G; Tedeschi G; Preziosi P
    Brain Res; 1979 Sep; 174(1):71-9. PubMed ID: 487124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonergic modulation of footshock induced aggression in paired rats.
    Datla KP; Mitra SK; Bhattacharya SK
    Indian J Exp Biol; 1991 Jul; 29(7):631-5. PubMed ID: 1839019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological profile of a model for central serotonin receptor activation.
    Matthews WD; Smith CD
    Life Sci; 1980 Apr; 26(17):1397-403. PubMed ID: 6247593
    [No Abstract]   [Full Text] [Related]  

  • 17. Antinociceptive action of quipazine: relation to central serotonergic receptor stimulation.
    Samanin R; Bernasconi S; Quattrone A
    Psychopharmacologia; 1976 Mar; 46(2):219-22. PubMed ID: 181775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a "serotonergic syndrome" in neonatal rat pups?
    Ristine LA; Spear LP
    Pharmacol Biochem Behav; 1985 Feb; 22(2):265-9. PubMed ID: 2858868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flumezapine, an antagonist of central dopamine and serotonin receptors.
    Fuller RW; Mason NR
    Res Commun Chem Pathol Pharmacol; 1986 Oct; 54(1):23-34. PubMed ID: 2879325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin and the mammalian circadian system: I. In vitro phase shifts by serotonergic agonists and antagonists.
    Prosser RA; Dean RR; Edgar DM; Heller HC; Miller JD
    J Biol Rhythms; 1993; 8(1):1-16. PubMed ID: 8490207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.